# The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease (review of Technology Appraisal No. 111): a systematic review and economic model.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-effectiveness-and-cost-effectiveness-of-donepezil-galantamine-rivastigmine/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Mark Bond,G Rogers,J Peters,Rodney P. Anderson,Martin Hoyle,A Miners,T Moxham,Sarah Davis,Praveen Thokala,Allan Wailoo,Mona Jeffreys,Christopher Hyde |
| Citations | 307 |
| DOI | 10.3310/hta16210 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://doi.org/10.3310/hta16210 |
| OpenAlex ID | https://openalex.org/W2000356307 |
| PMID | 22541366 |
| Type | review |
| Year | 2012 |

## Paper authors

- [Praveen Thokala](https://scholariq.org/researchers/praveen-thokala/)

## Paper journal

- [Health Technology Assessment](https://scholariq.org/journals/health-technology-assessment/)

## Paper primary topic

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)

## Paper topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Medical Case Reports and Studies](https://scholariq.org/topics/medical-case-reports-and-studies/)
- [Biological Research and Disease Studies](https://scholariq.org/topics/biological-research-and-disease-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.